Products and Services
RSSRegulatory & Toxicology
Evonik Röhm GmbH
We at Pharma Polymers recognize that in many cases our customers intend a global marketing of their pharmaceutical products and therefore have an essential interest in the international acceptance of EUDRAGIT®.
Click Here To Download:
•Product Overview: EUDRAGIT® Versatile Polymers For Oral Solid Dosage Formulations
We at Pharma Polymers recognize that in many cases our customers intend a global marketing of their pharmaceutical products and therefore have an essential interest in the international acceptance of EUDRAGIT®. In order to ensure that our products are in compliance with current and announced regulations, we adhere to the guidelines issued in the most current compendia and regulations including, but not limited to, the United States Pharmacopoeia (USP), European Pharmacopoeia (Ph. Eur), the Japanese Pharmacopoeia (JP), Japanese Pharmaceutical Excipients (JPE). Other international regulationsand compendia are also addressed when needed. Together with our national subsidiaries, agencies and representatives, we are at all times willing and prepared to assist our customers in matters concerning registration. Whenever needed, we will provide all pertinent and helpful information.
•Product Overview: EUDRAGIT® Versatile Polymers For Oral Solid Dosage Formulations
•Product Overview: EUDRAGIT® Versatile Polymers For Oral Solid Dosage Formulations
We at Pharma Polymers recognize that in many cases our customers intend a global marketing of their pharmaceutical products and therefore have an essential interest in the international acceptance of EUDRAGIT®. In order to ensure that our products are in compliance with current and announced regulations, we adhere to the guidelines issued in the most current compendia and regulations including, but not limited to, the United States Pharmacopoeia (USP), European Pharmacopoeia (Ph. Eur), the Japanese Pharmacopoeia (JP), Japanese Pharmaceutical Excipients (JPE). Other international regulationsand compendia are also addressed when needed. Together with our national subsidiaries, agencies and representatives, we are at all times willing and prepared to assist our customers in matters concerning registration. Whenever needed, we will provide all pertinent and helpful information.
The acceptability of EUDRAGIT® polymers is documented by pharmacopoeial monographs in the US National Formulary (NF), the European Pharmacopoeia (Ph. Eur.) and the Japanese PharmaceuticalExcipients (JPE), as detailed in our leaflet "Pharmacopoeial Monographs and Drug Master Files." These monographs have been elaborated in close co-operation with Pharma Polymers. Pharma Polymers continues to actively request and support the elaboration of NF, Ph. Eur. and JPE monographs.
Click Here To Download:•Product Overview: EUDRAGIT® Versatile Polymers For Oral Solid Dosage Formulations
